The NephroPlus IPO is set to open for subscription on December 10, 2025, and will close on December 12, 2025. NephroPlus is Asia’s largest dialysis services provider and the fifth largest in the world. With this IPO, the company aims to strengthen its expansion plans and support its long-term growth strategy.
Price Band and IPO Structure
The price band for the NephroPlus IPO is ₹438 to ₹460 per equity share. Eligible employees will receive a discount of ₹41 per share, making the IPO more attractive for internal stakeholders.
The offer includes two components:
- Fresh issue worth ₹353.4 crore
- Offer for sale (OFS) of 1,12,53,102 equity shares
The combination helps the company raise capital while also giving existing shareholders an exit option.
How NephroPlus Plans to Use the Funds
NephroPlus plans to deploy the funds from the fresh issue in two major areas.
First, the company will invest ₹129.1 crore in capital expenditure to open new dialysis clinics across India. This expansion will help the brand reach more patients who need reliable and affordable kidney-care services.
Second, NephroPlus will use ₹136 crore to pre-pay or repay existing borrowings. This step will improve the company’s financial stability and reduce interest costs, which is important for long-term growth.
Founded in 2009, NephroPlus has built India’s largest organized dialysis network. It operates clinics in 288 cities, across 21 states and 4 Union Territories. The company has also expanded internationally, running 519 clinics, including locations in Uzbekistan, Nepal, and the Philippines.
Its flagship 165-bed dialysis centre in Tashkent is the largest dialysis clinic in the world, showing the company’s global reach.
Diverse Dialysis Services for Patients
NephroPlus offers a full range of dialysis services, including:
- Haemodialysis
- Home haemodialysis
- Hemodiafiltration
- Dialysis on call
- Holiday dialysis
- Dialysis on wheels
These services give patients flexible and safe treatment options, whether at home, in a clinic, or while travelling.
With its wide network and global experience, NephroPlus is well-positioned to meet this demand. The NephroPlus IPO signals the company’s commitment to scaling its operations and improving access to kidney care across India and abroad.
